Value of dynamic contrast-enhanced MRI and DWI in diagnosis of prostate cancer and its pathological comparison

被引:0
|
作者
Shen, Yanyan [1 ]
Wu, Shiyong [1 ]
机构
[1] Huzhou Univ, Dept Radiol, Affiliated Hosp 1, Huzhou 313000, Zhejiang, Peoples R China
关键词
MRI; Dynamic enhancement; DWI; Prostatic carcinoma; Angiogenesis within cancer foci; DCE-MRI;
D O I
10.22514/jomh.2023.138
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study aims to assess the diagnostic utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) in the detection of prostate cancer (PCa) and to investigate the correlation between DCE-MRI signal intensity-time (SI-T) curve parameters and angiogenesis in cancerous lesions. A total of 56 PCa patients and 50 benign prostatic hyperplasia (BPH) patients were enrolled, and their DCE-MRI and DWI images before surgery were analyzed. We also examined the association between DCE-MRI SI-T curve parameters and vascular endothelial growth factor (VEGF) or microvessel density (MVD). In the early stage of DCEMRI, both PCa and BPH lesions exhibited higher enhancement levels compared to the surrounding normal prostate tissue, and during delayed scanning, BPH lesions and adjacent normal prostate tissue demonstrated substantial enhancement with minimal distinction. Conversely, PCa lesions exhibited relatively low signal intensity changes, distinguishing them from the surrounding normal tissue. Most SI-T curve patterns for PCa patients exhibited ascending and descending profiles, whereas BPH patients predominantly exhibited plateau or ascending curves (p < 0.05). PCa patients had lower peak times, higher enhancement degrees and rates, and elevated VEGF positivity rates and MVD counts compared to BPH patients (p < 0.05). Correlation analysis revealed a negative correlation between peak times of SI-T curve parameters and VEGF and MVD expression levels, while enhancement degree and rate exhibited positive correlations with these parameters (p < 0.05). In DWI images, hyperplastic foci were primarily isointense or slightly hyperintense, while cancerous foci were predominantly markedly hyperintense. Higher b-values were associated with lower apparent diffusion coefficient (ADC) values. However, across various b-values, PCa consistently exhibited lower ADC values than BPH (p < 0.05). DCE-MRI and DWI are valuable tools for distinguishing between PCa and BPH.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 50 条
  • [1] Is a quantitative analysis of dynamic contrast-enhanced MRI of added value for prostate cancer diagnosis?
    Turco, S.
    Fernandes, Dinis C.
    Miclea, R.
    Schoots, I. G.
    Nooijen, P.
    Van der Linden, H.
    Barentsz, J.
    Heijmink, S.
    Wijkstrah, H.
    Mischi, M.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S706 - S707
  • [2] Overview of Dynamic Contrast-Enhanced MRI in Prostate Cancer Diagnosis and Management
    Verma, Sadhna
    Turkbey, Baris
    Muradyan, Naira
    Rajesh, Arumugam
    Cornud, Francois
    Haider, Masoom A.
    Choyke, Peter L.
    Harisinghani, Mukesh
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (06) : 1277 - 1288
  • [3] Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI
    Hoetker, Andreas M.
    Mazaheri, Yousef
    Aras, Oemer
    Zheng, Junting
    Moskowitz, Chaya S.
    Gondo, Tatsuo
    Matsumoto, Kazuhiro
    Hricak, Hedvig
    Akin, Oguz
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 206 (04) : 756 - 763
  • [4] Dynamic contrast-enhanced MRI for prostate cancer localization
    Jackson, A. S. N.
    Reinsberg, S. A.
    Sohaib, S. A.
    Charles-Edwards, E. M.
    Jhavar, S.
    Christmas, T. J.
    Thompson, A. C.
    Bailey, M. J.
    Corbishley, C. M.
    Fisher, C.
    Leach, M. O.
    Dearnaley, D. P.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2009, 82 (974): : 148 - 156
  • [5] The Added Value of Dynamic Contrast-enhanced Sequences in Prostate MRI
    Withey, Samuel J.
    Amlani, Ashik
    [J]. RADIOLOGY-IMAGING CANCER, 2020, 2 (05):
  • [6] Comparison of Dynamic Contrast-Enhanced MRI and Dynamic Contrast-Enhanced CT Biomarkers in Bladder Cancer
    Naish, J. H.
    McGrath, D. M.
    Bains, L. J.
    Passera, K.
    Roberts, C.
    Watson, Y.
    Cheung, S.
    Taylor, M. B.
    Logue, J. P.
    Buckley, D. L.
    Tessier, J.
    Young, H.
    Waterton, J. C.
    Parker, G. J. M.
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2011, 66 (01) : 219 - 226
  • [7] Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer
    Turnbull, Lindsay W.
    [J]. NMR IN BIOMEDICINE, 2009, 22 (01) : 28 - 39
  • [8] The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment
    Turkbey, Baris
    Thomasson, David
    Pang, Yuxi
    Bernardo, Marcelino
    Choyke, Peter L.
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2010, 16 (03) : 186 - 192
  • [9] Interscanner Comparison of Dynamic Contrast-Enhanced MRI in Prostate Cancer 1.5 Versus 3 T MRI
    Sertdemir, Metin
    Schoenberg, Stefan O.
    Sourbron, Steven
    Hausmann, Daniel
    Heinzelbecker, Julia
    Michaely, Henrik J.
    Dinter, Dietmar J.
    Weidner, Anja M.
    [J]. INVESTIGATIVE RADIOLOGY, 2013, 48 (02) : 92 - 97
  • [10] Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI
    Puech, Philippe
    Betrouni, Nacim
    Viard, Romain
    Villers, Amauld
    Leroy, Xavier
    Leiria Laurent, Tre
    [J]. 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 5567 - +